The Danish government and the foundation behind Novo Nordisk A/S will invest €80 million ($93 million) in a Microsoft-powered ...

Denmark's Export and Investment Fund (EIFO) and the Novo Nordisk Foundation (NNF) are set to invest €80 million ($92.93m) to ...

COPENHAGEN, Denmark, Dec. 8, 2020 /PRNewswire/ -- The Novo Nordisk Foundation today announces that BioInnovation Institute (BII), a Novo Nordisk F ...

Denmark is investing 80 million euro in a quantum computing project intended to bring a commercial-grade system to the Nordic ...

The Novo Nordisk Foundation is considered a “shareholder foundation” or “enterprise foundation,” meaning that it controls a majority stake in the corporate entities Novo Nordisk and Novozymes. That ...

LONDON (Reuters) - The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded foreign aid, and will continue to focus on its core ...

The Novo Nordisk Foundation, top shareholder of Danish obesity drugmaker Novo Nordisk, plans to give a larger portion of its social, scientific and humanitarian grants outside of Denmark, ...

Novo Nordisk Foundation's nine-person board includes former Novo CEO and current board chairman Lars Rebien Sørensen, University of Copenhagen professor Liselotte Højgaard, ...

Novo Nordisk’s main shareholder — the Novo Nordisk Foundation — initiated the move. The century-old nonprofit foundation has 75% of the voting rights and holds just under a third of the ...

The Novo Nordisk Foundation, the philanthropic fund behind the maker of blockbuster drugs Ozempic and Wegovy, will give more donations to stem-cell based therapies as part of a shift in its focus ...